Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study

NCT05594901 is registered in ClinicalTrials.gov with University of Bologna as lead sponsor.

NCT NCT05594901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05594901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study
Lead sponsor
University of Bologna
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2022
Completion date
June 30, 2025
Enrollment
240 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

carbapenem-resistant enterobacteriaceae colonization, liver transplantation